Rooting for Remdesivir; Pharmaceuticals & the Push for Progress

Rooting for Remdesivir; Pharmaceuticals & the Push for Progress

  • Af
  • Episode
      162
  • Published
      17. apr. 2020
  • Forlag
0 Anmeldelser
0
Episode
162 of 1786
Længde
21M
Sprog
Engelsk
Format
Kategori
Økonomi & Business

Gilead’s experimental Covid-19 treatment caught the markets’ attention after STAT News reported encouraging early results in its phase 3 trial. Former FDA Commissioner Dr. Scott Gottlieb explains the antiviral Remdesivir and explains its potential role in flattening the pandemic’s curve. French pharmaceutical company Sanofi has partnered with peer GlaxoSmithKline to develop a Covid-19 vaccine in the next 18 months. Sanofi has also partnered with a startup to create a coronavirus test using a smartphone. CEO Paul Hudson explains the news, the technology, and the path ahead for a healthier planet.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036
Cover for Rooting for Remdesivir; Pharmaceuticals & the Push for Progress

Other podcasts you might like ...